Pulmonary Hypertension (ph) Clinical Trials
3 recruiting trials for Pulmonary Hypertension (ph). Eligibility criteria explained in plain English.
TrialFinderData lists 3 Pulmonary Hypertension (ph) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Technische Universität Dresden (1), Hospital General Universitario Gregorio Marañon (1), Istanbul Mehmet Akif Ersoy Educational and Training Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Balloon Pulmonary Angioplasty (procedure, 1 trial).
Track Pulmonary Hypertension (ph) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
COMPERA / COMPERA-KIDS
In view of the manifold options for mono- and combination therapy that have now emerged for patients with pulmonary (arterial) hypertension (PH/PAH), controlled clinical trials...
Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension.
Previous data from our group showed reduced BMPR2 isoform A in pulmonary hypertension associated with left heart disease (PH-LHD) of valvular origin. Focusing on dysregulation of...
Arterial Wave Energy Flux and Multidimensional Recovery in Patients With Chronic Thromboembolic Pulmonary Hypertension...
The goal of this observational study is to learn if advanced heart pressure wave analysis (called WIA and REPA) can help track and predict clinical improvement in adults (aged...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Pulmonary Hypertension (ph), with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Pulmonary Hypertension (ph), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Pulmonary Hypertension (ph), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.